|
Volumn 734, Issue 1, 1999, Pages 55-61
|
Quantitative determination of efavirenz (DMP 266), a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection
|
Author keywords
DMP 266; Efavirenz
|
Indexed keywords
EFAVIRENZ;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
ARTICLE;
BLOOD ANALYSIS;
CLINICAL ARTICLE;
DRUG DETERMINATION;
DRUG STABILITY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
QUANTITATIVE ASSAY;
REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
ULTRAVIOLET SPECTROSCOPY;
ACETONITRILES;
ANTI-HIV AGENTS;
BLOOD PROTEINS;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
DRUG MONITORING;
DRUG STABILITY;
HUMANS;
OXAZINES;
PRECIPITATION;
QUALITY CONTROL;
REVERSE TRANSCRIPTASE INHIBITORS;
SENSITIVITY AND SPECIFICITY;
|
EID: 0032879058
PISSN: 13872273
EISSN: None
Source Type: Journal
DOI: 10.1016/S0378-4347(99)00336-9 Document Type: Article |
Times cited : (59)
|
References (10)
|